The candidate is expected to perform study design and execution to investigate Alzheimer's disease pathogenesis and explore drug development. Primary human neuronal culture from induced pluripotent stem cells, transgenic rodent models, and human clinical samples (blood and postmortem brain tissue) will be utilized for biochemical analysis using advance analytic instruments. Large data set is expected to be generated and analyzed including gene expression and proteomic profiles.
A PhD level scientist with postdoctoral research experience in biochemical and cellular biology of disease pathogenesis is required. Prior experience in mass spectrometry-based analytic work is preferred.
PLEASE DO NOT APPLY THROUGH THE BU WEBSITE
Please email CV to Weiming Xia, PhD, Professor, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine (firstname.lastname@example.org).
We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability status, protected veteran status, or any other characteristic protected by law. We are a VEVRAA Federal Contractor.
Internal Number: 2490
About Boston University
Boston University is no small operation. With over 33,000 undergraduate and graduate students from more than 140 countries, 10,000 faculty and staff, 16 schools and colleges, and 250 fields of study, our two campuses are always humming.